The researchers also learned more about lymphoma itself
Pei Chuan Li is the lead author of the study, as well as a postdoctoral fellow within Shih's lab. He explained their results, "combining MAO-A inhibitors with current treatment was more effective than each treatment alone."
In this study, the researchers also discovered that analyzing MAO-A in Hodgkin's lymphoma may actually offer information into the biology of the lymphoma itself. By obtaining this information, researchers will have further access into how lymphomas vary - enabling more precise diagnosis that may aid patients who previously showed "grey area" symptoms, which means that their condition was hard to differentiate from other forms of lymphoma.